Modelling estimates of the burden of respiratory syncytial virus infection in children in the UK

Sylvia Taylor, Robert J Taylor, Roger L Lustig, Cynthia Schuck-Paim, François Haguinet, David J Webb, John Logie, Gonçalo Matias, Douglas M Fleming, Sylvia Taylor, Robert J Taylor, Roger L Lustig, Cynthia Schuck-Paim, François Haguinet, David J Webb, John Logie, Gonçalo Matias, Douglas M Fleming

Abstract

Objective: The burden of respiratory syncytial virus (RSV) illness is not well characterised in primary care. We estimated the burden of disease attributable to RSV in children in the UK between 1995 and 2009.

Design: Time-series regression modelling.

Setting: A multiple linear regression model based on weekly viral surveillance (RSV and influenza, Public Health England), and controlled for non-specific seasonal drivers of disease, estimated the proportion of general practitioner (GP) episodes of care (counted as first visit in a series within 28 days; Clinical Practice Research Datalink, CPRD), hospitalisations (Hospital Episode Statistics, HES) and deaths (Office of National Statistics, ONS) attributable to RSV each season.

Participants: Children 0-17 years registered with a GP in CPRD, or with a respiratory disease outcome in the HES or ONS databases.

Primary outcome measures: RSV-attributable burden of GP episodes, hospitalisations and deaths due to respiratory disease by age. RSV-attributable burden associated with selected antibiotic prescriptions.

Results: RSV-attributable respiratory disease in the UK resulted in an estimated 450 158 GP episodes, 29 160 hospitalisations and 83 deaths per average season in children and adolescents, with the highest proportions in children <6 months of age (14 441/100 000 population, 4184/100 000 and 6/100 000, respectively). In an average season, there were an estimated 125 478 GP episodes for otitis media and 416 133 prescriptions for antibiotics attributable to RSV. More GP episodes, hospitalisations and deaths from respiratory disease were attributable to RSV than to influenza in children under 5 years.

Conclusions: The burden of RSV in children in the UK exceeds that of influenza. RSV in children and adolescents contributes substantially to GP office visits for a diverse range of illnesses, and was associated with an average 416 133 prescribed antibiotic courses per season. Effective antiviral treatments and preventive vaccines are urgently needed for the management of RSV infection in children.

Trial registration number: NCT01706302.

Keywords: Children; Mortality; Otitis Media; Respiratory syncytial virus.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Figures

Figure 1
Figure 1
Seasonal incidence (per 100 000) of general practice episodes (A), hospitalisations (B) and deaths (C) due to respiratory syncytial virus-attributable respiratory disease (broadly defined) by age. Vertical lines=95% CIs.

References

    1. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001;344:1917–28.
    1. Fleming DM, Elliot AJ. Lessons from 40 years’ surveillance of influenza in England and Wales. Epidemiol Infect 2008;136:866–75. 10.1017/S0950268807009910
    1. Fleming DM, Pannell RS, Elliot AJ et al. . Respiratory illness associated with influenza and respiratory syncytial virus infection. Arch Dis Child 2005;90:741–6. 10.1136/adc.2004.063461
    1. Nair H, Nokes DJ, Gessner BD et al. . Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010;375:1545–55. 10.1016/S0140-6736(10)60206-1
    1. Deshpande SA, Northern V. The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area. Arch Dis Child 2003;88:1065–9. 10.1136/adc.88.12.1065
    1. Pitman RJ, Melegaro A, Gelb D et al. . Assessing the burden of influenza and other respiratory infections in England and Wales. J Infect 2007;54:530–8. 10.1016/j.jinf.2006.09.017
    1. Thompson WW, Shay DK, Weintraub E et al. . Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179–86. 10.1001/jama.289.2.179
    1. Simonsen L, Taylor RJ, Young-Xu Y et al. . Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. MBio 2011;2:e00309–10. 10.1128/mBio.00309-10
    1. Williams T, van Staa T, Puri S et al. . Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource. Ther Adv Drug Saf 2012;3:89–99. 10.1177/2042098611435911
    1. Brock A, Griffiths C, Rooney C. The impact of introducing ICD-10 on analysis of respiratory mortality trends in England and Wales. Health Stat Q 2006;29:9–17.
    1. ONS. Taxonomy. Office for National Statistics, 2010. (accessed 17 Dec 2013).
    1. Patel JA, Nguyen DT, Revai K et al. . Role of respiratory syncytial virus in acute otitis media: implications for vaccine development. Vaccine 2007;25:1683–9. 10.1016/j.vaccine.2006.10.045
    1. Nokso-Koivisto J, Räty R, Blomqvist S et al. . Presence of specific viruses in the middle ear fluids and respiratory secretions of young children with acute otitis media. J Med Virol 2004;72:241–8. 10.1002/jmv.10581
    1. Heikkinen T, Thint M, Chonmaitree T. Prevalence of various respiratory viruses in the middle ear during acute otitis media. N Engl J Med 1999;340:260–4. 10.1056/NEJM199901283400402
    1. Debiaggi M, Canducci F, Ceresola ER et al. . The role of infections and coinfections with newly identified and emerging respiratory viruses in children. Virol J 2012;9:247 10.1186/1743-422X-9-247
    1. Department of Health. Joint Committee on Vaccination and Immunisation. JCVI statements, advice and recommendations. (accessed 23 Apr 2015).
    1. Zhou H, Thompson WW, Viboud CG et al. . Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993–2008. Clin Infect Dis 2012;54:1427–36. 10.1093/cid/cis211
    1. Fleming DM, Pannell RS, Cross KW. Mortality in children from influenza and respiratory syncytial virus. J Epidemiol Community Health 2005;59:586–90. 10.1136/jech.2004.026450
    1. Hardelid P, Pebody R, Andrews N. Mortality caused by influenza and respiratory syncytial virus by age group in England and Wales 1999–2010. Influenza Other Respir Viruses 2013;7:35–45. 10.1111/j.1750-2659.2012.00345.x
    1. Lipsitch M, Tchetgen Tchetgen E, Cohen T. Negative controls: a tool for detecting confounding and bias in observational studies. Epidemiology 2010;21:383–8. 10.1097/EDE.0b013e3181d61eeb
    1. Paget WJ, Balderston C, Casas I et al. . Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project. Eur J Pediatr 2010;169:997–1008. 10.1007/s00431-010-1164-0
    1. Stockman LJ, Curns AT, Anderson LJ et al. . Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997–2006. Pediatr Infect Dis J 2012;31:5–9. 10.1097/INF.0b013e31822e68e6
    1. Hall CB, Weinberg GA, Iwane MK et al. . The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009;360:588–98. 10.1056/NEJMoa0804877
    1. Forster J, Ihorst G, Rieger CH et al. . Prospective population-based study of viral lower respiratory tract infections in children under 3 years of age (the study). Eur J Pediatr 2004;163:709–16. 10.1007/s00431-004-1523-9
    1. Fleming DM, Taylor R, Lustig R et al. . The burden of respiratory syncytial virus (RSV) infection in adults and the elderly in the United Kingdom. RSV Vaccines for the World. Porto; Portugal: 14–16 October 2013.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner